IDO1 and rheumatoid arthritis: In the case of RA, we have demonstrated that the inhibition of IDO (by 1-methyl-DL-tryptophan) or deletion of IDO1 increased the severity of arthritic symptoms in the collagen-induced model of arthritis (CIA) (8).